This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

News Articles: Innovationrss feed

Currently Filtering By:Innovation clear filter

Dozens of mammals could be susceptible to SARS-CoV-2

Numerous animals may be vulnerable to SARS-CoV-2, the virus that causes Covid-19, according to a large study modelling how the virus might infect different animals’ cells, involving Oxford Brookes University academics.  The study which was led by UCL and published in Scientific Reports reports evidence that 26 animals regularly in contact with people may be susceptible […]

IMPOWER and Oxford University Hospitals NHS Foundation Trust sign collaboration agreement

Oxford University Hospitals NHS Foundation Trust and IMPOWER Consulting have announced a collaborative working agreement in relation to improving impact to health and social care. The aim of the partnership is two-fold. Using its advanced capabilities in technology and digital, the Trust will work with IMPOWER to drive innovation that will benefit health and social […]

Oxford’s OpenABM-Covid19 mathematical model helps UK and other countries to control the coronavirus epidemic

A team of mathematical modellers and epidemiologists at Oxford University’s Nuffield Department of Medicine release the latest model of a population responding to the coronavirus epidemic. The model – OpenABM-Covid19 – provides public health decision-makers with the ability to review the potential progression and outcome of the coronavirus, including fluctuations in infected individuals, hospitalisations, intensive care unit […]

Funding received for new COVID-19 vaccine developed using insect cells

Oxford Brookes spinout company Oxford Expression Technologies has been awarded a grant from Innovate UK to support a partnership with Vaxine Pty Ltd to develop a vaccine for COVID-19. The grant will accelerate the creation of the Covax-19® vaccine, which is being developed by Vaxine, an Australian biotechnology company focussing on the development of innovative […]

Global consortium launches new study into long-term effects of COVID-19

The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), based at Oxford University, in collaboration with Dr Janet Scott, of the MRC-University of Glasgow’s Centre for Virus Research, has launched a longitudinal observational study to measure prevalence and risk factors of long-term health and psycho-social consequences of COVID-19. The researchers are inviting hospitals and […]

Mental Health – difficult conversations in the workplace

People working across Buckinghamshire are benefiting from mental health support at work. Oxford Health’s mental health employment support services are teaching local business leaders how to support staff with their mental health during the coronavirus pandemic. The training is being offered to employers and managers in the county in partnership with county business forum Buckinghamshire […]

Development of Oxford COVID-19 vaccine expands into US Phase III clinical trial

A new arm of the ongoing global clinical trials of the ChAdOx1 nCoV-19 vaccine led by AstraZeneca has launched in the US to assess safety, efficacy and immunogenicity of the vaccine for the prevention of COVID-19. Our vaccine work is progressing quickly. To ensure you have the latest information or to find out more about […]

LOW-DOSE CORTICOSTEROIDS FOUND TO REDUCE MORTALITY IN PATIENTS WITH SEVERE COVID-19

Oxford patients, clinicians and researchers have contributed important data to new global research which shows that corticosteroids can significantly improve outcomes for severely ill patients with COVID-19. Four research papers published today in the Journal of the American Medical Association (JAMA) reinforce evidence that these inexpensive and widely available drugs improve outcomes for the most critically […]

OUH’S CELLULAR PATHOLOGY DEPARTMENT ACHIEVES 100% DIGITISATION OF SURGICAL HISTOLOGY SLIDES

With support from Royal Philips, Oxford University Hospitals (OUH) NHS Foundation Trust has become one of the earliest UK adopters of a fully digitised cellular pathology (histopathology) department. OUH is one of the first NHS trusts in the country to achieve the milestone of digitising all surgical histology and referral slides within the cellular pathology department. This […]

GOVERNMENT BOOST FOR DIGITISATION AND AI IN PATHOLOGY SERVICES

Oxford University Hospitals (OUH) is one of the NHS trusts that will benefit from a £13.5m national funding boost to further enhance cellular pathology services and provide faster and more accurate diagnosis of deadly diseases such as cancer.  The PathLAKE (Pathology Image Data Lake for Analytics Knowledge and Education) digital pathology consortium, led by University Hospital […]